Specialty Areas: Advanced heart failure and cardiac transplantation; mechanical circulatory support; critical care medicine; transthoracic and transesophageal echocardiography; flexible bronchoscopy; thoracentesis and tube thoracotomy; cardiovascular clinical trials.
Chronology: MD: University of North Carolina, 2000; Intern and Resident: University of Texas-Southwestern, 2000-2005; Clinical Research Fellowship in Cardiovascular: Duke University, 2007-2009; Postgraduate Fellowship in Critical Care: Duke University 2008-2009; MHS: Duke University, 2010; Chief Medicine Resident, Assistant Instructor, Internal Medicine: University of Texas-Southwestern, 2004-2008; Assistant Professor of Medicine (Cardiology & Pulmonary/Critical Care): University of North Carolina, 2009-2015; Medical Director, Cardiac Intensive Care Unit: University of North Carolina, 2010-present; Director, Cardiovascular Clinical Trials: University of North Carolina, 2011-present; Medical Director, Cardiovascular & Thoracic Surgical Intensive Care Unit & Critical Care Service: University of North Carolina, 2013-present; Medical Director, UNC Mechanical Heart Program: University of North Carolina, 2014-present; Associate Professor of Medicine: University of North Carolina, 2015-present.
Dr. Katz’s research interests include cardiogenic shock and mechanical circulatory support, hypertensive crises, and cardiovascular critical care outcomes as well as targeted temperature management for cardiac arrest survivors. His clinical interests include advanced heart failure and transplantation, critical care and general cardiology.
In 2015, Dr. Katz was named as a Health Care Hero by the Triangle Business Journal to honor his work and dedication to patients with end-stage heart disease. He is also a sought-after expert on the structure and care delivery within a Cardiac Intensive Care Unit (CICU).
Van Diepen S, Lin M, Bakal JA, McAlister FA, Kaul P, Katz JN, Fordyce CB, Southern DA, Graham MM, Wilton SB, Newby LK, Granger CB, Ezekowitz JA. Do stable non-ST-segment elevation acute coronary syndromes require admission to coronary intensive care units? Am Heart J, 2016; doi:10.1016/j.ahj.2015.11.020. # of pages: 28.
Katz JN, Jensen BC, Chang PP, Myers SL, Pagani FD, Kirklin JK. A multicenter analysis of clinical hemolysis in patients supported with durable, long-term left ventricular assist device therapy. J Heart Lung Transplant, 2015;34:701-9. # of pages: 9.
Katz JN, Adamson RM, John R, Tatooles A, Sundareswaran K, Kallel F, Farrar DJ, Jorde UP, on behalf of the Study of Reduced Anti-Coagulation/Anti-platelet Therapy in Patients with the HeartMate II LVAS (TRACE). Safety of reduced anti-thrombotic strategies in HeartMate II patients: A one-year analysis of the US-TRACE Study. J Heart Lung Transplant, 2015. [epub ahead of print]. # of pages: 10.
Kiernan MS, Joseph SM, Katz JN, Kilic A, Rich JD, Lyons J, Bethea B, Eckman P, Gosev I, Lee S, Soleimani B, Takayama H, Patel CB, Uriel N. Sharing the care of mechanical circulatory support: Collaborative efforts of patients/caregivers, shared-care sites, and LVAD implanting centers. Circ Heart Fail, 2015;8:629-35. # of pages: 7.
Pauley E, Lishmanov A, Schumann S, van Diepen S, Katz JN. Delirium is a robust predictor of morbidity and mortality among critically ill patients treated in a cardiac intensive care unit. Am Heart J, 2015;170:79-86. # of pages: 8.
Hill T, Means G, van Diepen S, Paul T, Katz JN. Cardiovascular critical care: a perceived deficiency among US trainees. Crit Care Med, 2015;43:1853-8. # of pages: 6.
van Diepen S, Granger CB, Jacka M, Gilchrist IC, Morrow DA, Katz JN. The unmet need for addressing cardiac issues in intensive care research. Crit Care Med, 2015;43:128-34. # of pages: 7.
Katz JN, Waters SB, Hollis IB, Chang PP. Advanced therapies for end-stage heart failure. Curr Cardiol Rev, 2015;11:63-72. # of pages: 10.